Karyopharm Therapeutics (KPTI) trading halted with news pending
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Karyopharm Therapeutics (NASDAQ: KPTI) trading halted with news pending.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI):Selinexor At ASH Could Drive Upside - Jefferies
- PAVmed (PAVM) halted on LUDP
- GenVec (GNVC) halted on LUDP, last up 9.2%